WASHINGTON, June 14 -- Boston Scientific Corp., Marlborough, Massachusetts, submitted a public comment letter to the Centers for Medicare & Medicaid Services (CMS) expressing its recommendations on the proposed Fiscal Year 2027 Medicare inpatient and long-term care hospital prospective payment systems. The company, which develops medical devices for various specialties including cardiac rhythm management and interventional cardiology, emphasized the need for CMS to update payment classifications  more

WASHINGTON, June 14 -- Orca1, a healthcare technology and supply chain management company based in Boston, Massachusetts, submitted a public comment letter to the Centers for Medicare & Medicaid Services (CMS). The letter responds to CMS's proposed rule on Unique Device Identification (UDI) requirements for implantable medical devices, emphasizing broader patient safety, device traceability, and post-market surveillance goals. Orca1 highlights significant concerns about CMS's proposed reliance o  more

WASHINGTON, June 14 -- The Center for Addiction Science, Policy, and Research, a pharma-independent nonprofit based in Boston, Massachusetts, submitted a public comment letter to the U.S. Food and Drug Administration (FDA) addressing the agency's request for information on drug repurposing to meet unmet medical needs. CASPR emphasized the critical need to prioritize substance use disorders (SUD) within drug repurposing efforts and proposed a novel framework for advancing off-patent medications t  more

BOSTON, Massachusetts, June 14 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release: * * * Fixed-Duration Triplet Therapy Demonstrates Efficacy for Patients with Relapsed/Refractory CLL * A Dana-Farber Cancer Institute investigator presented positive interim data from the BRUIN CLL-322 trial, the first randomized phase 3 data to be reported about a Bruton tyrosine kinase (BTK) inhibitor as part of a fixed-duration therapy in relapsed/refractory chroni  more

WASHINGTON, June 14 -- PACE Head Start, Cambridge, Massachusetts, has urged the U.S. Department of Health and Human Services to address compensation and workforce stability issues facing Head Start programs nationwide. In a public comment letter submitted regarding the Notice of Proposed Rule Making Restoring Flexibility To Support Head Start Program Access, the organization expressed concern about stagnant funding and wage disparities that undermine staff retention and recruitment. The letter   more

BOSTON, Massachusetts, June 11 -- The Massachusetts Department of Elementary and Secondary Education posted the following news release: * * * Healey-Driscoll Administration Hosts Statewide Civics Project Showcases 1,150 students from 80 districts participated in events in Boston, Dartmouth, Springfield and Worcester - EVERETT - The Healey-Driscoll Administration hosted four Massachusetts Civics Project Showcases in collaboration with Generation Citizen between May 26 and June 5 in Springfie  more

BOSTON, Massachusetts, June 14 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release: * * * ImmunoPRISM Trial Shows Teclistamab Improves Depth of Response and Progression-Free Survival in High-Risk Smoldering Multiple Myeloma * Dana-Farber Cancer Institute investigators presented encouraging positive results from the phase 2 ImmunoPRISM trial, a first-of-its-kind randomized trial of teclistamab, a BCMA-targeted bispecific antibody, in high-risk smolder  more

WASHINGTON, June 15 -- The Massachusetts Health and Hospital Association, Boston, provided substantial input to the Centers for Medicare & Medicaid Services (CMS) concerning the agency's proposed inpatient hospital payment policies for fiscal year 2027. The public comment letter addressed several aspects of the Medicare Program, including payment updates, disproportionate share hospital payments, outlier payment thresholds, and other policy modifications under consideration by the U.S. Departmen  more

WASHINGTON, June 15 -- The Massachusetts Medical Device Industry Council (MassMEDIC), headquartered in Boston, Massachusetts, has expressed strong opposition to the U.S. Centers for Medicare & Medicaid Services (CMS) proposal to eliminate alternative payment pathways under the FY 2027 Hospital Inpatient Prospective Payment System (IPPS) and Outpatient Prospective Payment System (OPPS) for FDA-designated Breakthrough Devices. MassMEDIC, representing over 500 medical technology companies in Massa  more

WASHINGTON, June 15 -- Medical Information Technology, Inc., headquartered in Westwood, Massachusetts, has submitted a public comment letter to the Centers for Medicare & Medicaid Services (CMS), part of the U.S. Department of Health and Human Services, addressing proposed changes to the Medicare Program's Hospital Inpatient Prospective Payment Systems and related quality reporting policies for Fiscal Year 2027. The company, known for its Expanse electronic health record (EHR) system used in 29  more

WASHINGTON, June 15 -- PACE Head Start, New Bedford, Massachusetts, submitted a public comment letter to the U.S. Department of Health and Human Services regarding the Notice of Proposed Rule Making on restoring flexibility to support Head Start program access. The letter emphasized the urgent need for higher wages and enhanced benefits for the Head Start workforce to ensure the program's stability and effectiveness. PACE Head Start highlighted the significant role the program plays in providin  more

WASHINGTON, June 15 -- Philips, a health technology company headquartered in Cambridge, Massachusetts, submitted a public comment letter to the Centers for Medicare and Medicaid Services in response to the FY 2027 Medicare Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospitals proposed rule. The letter addresses key issues pertaining to Medicare Severity Diagnosis Related Groups (MS-DRGs) updates, the New Technology Add-On Payment (NTAP) program, and quality programs i  more

WASHINGTON, June 15 -- Proof, headquartered in Boston, Massachusetts, has submitted a public comment letter to the Office of the Comptroller of the Currency regarding proposed reforms to anti-money laundering and countering the financing of terrorism programs under the Bank Secrecy Act. The letter focuses on advancing the use of verifiable digital credentials (VDCs) to aid financial institutions in complying with these regulations. The letter highlights that VDCs are cryptographically secured d  more

WASHINGTON, June 14 -- Proof, a digital identity and transaction security platform based in Boston, Massachusetts, submitted a public comment letter to the Financial Crimes Enforcement Network (FinCEN) regarding proposed anti-money laundering (AML), countering the financing of terrorism (CFT), and sanctions compliance requirements for permitted payment stablecoin issuers (PPSIs) under the GENIUS Act. The company urged FinCEN to explicitly allow PPSIs to use verifiable digital credentials (VDCs)   more

WASHINGTON, June 15 -- Tilde Sciences LLC, headquartered in Boston, Massachusetts, has submitted a public comment letter to the U.S. Food and Drug Administration (FDA) addressing challenges and opportunities in developing repurposed drugs for addressing unmet medical needs. The company focuses on TLD-005, an oral formulation of mecamylamine, currently marketed as Vecamyl, to treat Sleep-Related Hypermotor Epilepsy (SHE), an ultra-rare and debilitating neurological disorder with no approved thera  more

WASHINGTON, June 15 -- Tokenization Systems, headquartered in Boston, Massachusetts, submitted a supplemental public comment letter to the Financial Crimes Enforcement Network (FinCEN) concerning the risks associated with Permitted Payment Stablecoin Issuers (PPSIs) and their reserve custody relationships. The comment builds on a previous filing, emphasizing newly available first-party causal evidence showing how concentration risk in reserve custody can cause significant stablecoin price disrup  more

WASHINGTON, June 15 -- Tufts Medicine, a Burlington, Massachusetts-based health system, submitted a public comment letter to the Centers for Medicare & Medicaid Services (CMS) addressing the agency's proposed Hospital Inpatient Prospective Payment Systems (IPPS) rule for fiscal year 2027. The letter outlines significant concerns related to payment updates for acute care hospitals, adjustments to uncompensated care payments, proposed quality metric changes, and value-based care models, emphasizin  more